Long-term prognosis of bipolar I disorder

被引:64
|
作者
Turvey, CL [1 ]
Coryell, WH
Solomon, DA
Leon, AC
Endicott, J
Keller, MB
Akiskal, H
机构
[1] Univ Iowa, Dept Psychiat, Psychiat Res MEB, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Iowa City, IA 52242 USA
[3] Brown Univ, Sch Med, Providence, RI 02912 USA
[4] Cornell Univ, Med Ctr, New York Hosp, New York, NY 10021 USA
[5] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[6] Univ Calif San Diego, Coll Med, San Diego, CA 92103 USA
关键词
bipolar disorder; mood disorders; prognosis; longitudinal studies;
D O I
10.1111/j.1600-0447.1999.tb07208.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This study examined the contribution of demographic, syndromal and longitudinal course variables to the long-term prognosis of 165 bipolar patients prospectively observed over 10 years as part of the National Institute of Mental Health Collaborative Study of Depression. Although most baseline clinical and demographic variables were not strong prognostic indicators, switching polarity within episodes was. Most episodes among the poor-prognosis patients were polyphasic, while most episodes among the comparison group with a better prognosis were monophasic. There was no evidence of shortening of cycle lengths over follow-up for either the poor-prognosis group or the entire sample. The relevance of these findings to the 'kindling' model is discussed.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
  • [41] Genetics of long-term treatment outcome in bipolar disorder
    Fabbri, Chiara
    Serretti, Alessandro
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 65 : 17 - 24
  • [42] Genetics of long-term treatment outcome in bipolar disorder
    Fabbri, C.
    Serretti, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S159 - S160
  • [43] GENETICS OF LONG-TERM TREATMENT OUTCOME IN BIPOLAR DISORDER
    Fabbri, Chiara
    Serretti, Alessandro
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S325 - S326
  • [44] THE PHENOMENOLOGY OF BIPOLAR DISORDER: WHAT DRIVES THE HIGH RATE OF MEDICAL BURDEN AND DETERMINES LONG-TERM PROGNOSIS?
    Soreca, Isabella
    Frank, Ellen
    Kupfer, David J.
    DEPRESSION AND ANXIETY, 2009, 26 (01) : 73 - 82
  • [45] Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder
    Vieta, Eduard
    Suppes, Trisha
    Ekholm, Birgit
    Udd, Mattias
    Gustafsson, Urban
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 142 (1-3) : 36 - 44
  • [46] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G.
    Lu, K.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    BIPOLAR DISORDERS, 2013, 15 : 134 - 134
  • [47] LONG-TERM EFFICACY OF QUETIAPINE IN COMBINATION WITH LITHIUM OR DIVALPROEX ON MIXED SYMPTOMS IN BIPOLAR I DISORDER
    Vieta, E.
    Suppes, T.
    Gustafsson, U.
    Paulsson, B.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [48] Aripiprazole in combination with lamotrigine: long-term treatment of patients with bipolar I disorder (manic or mixed)
    Ketter, T.
    Carlson, B. X.
    Sun, W.
    Timko, K.
    Vester-Blokland, E.
    McQuade, R. D.
    Sanchez, R.
    Owen, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S413 - S414
  • [49] Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients
    Post, Robert M.
    Leverich, Gabriele S.
    Altshuler, Lori L.
    Frye, Mark A.
    Suppes, Trisha
    McElroy, Susan L.
    Keck, Paul E., Jr.
    Nolen, Willem A.
    Rowe, Mike
    Kupka, Ralph W.
    Grunze, Heinz
    Goodwin, Frederick K.
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (07) : 924 - 930
  • [50] Long-term safety and efficacy of olanzapine in the treatment of japanese patients with bipolar I disorder, depressed
    Katagiri, H.
    Tohen, M.
    McDonnell, D. Patrick
    Fujikoshi, S.
    Case, M.
    Kanba, S.
    Takahashi, M.
    Gomez, J. -C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 82 - 83